Skip to main content
Erschienen in: Current Diabetes Reports 4/2010

01.08.2010

Diabetic Foot Disease in People with Advanced Nephropathy and Those on Renal Dialysis

verfasst von: Agbor Ndip, Lawrence A. Lavery, Andrew J. M. Boulton

Erschienen in: Current Diabetes Reports | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Among the spectrum of risk for diabetic foot disease conferred by chronic kidney disease (CKD), end-stage renal disease (ESRD) has emerged as a novel independent risk factor. Apart from the classical triad of neuropathy, infection, and peripheral arterial disease that operate in these individuals, the risk is further compounded by inadequate foot self-care by patients and by dialysis centers not providing onsite foot care, as medical priorities are diverted to the dialysis itself. Consequently, the burden of diabetic foot disease has increased in the CKD and ESRD population as exemplified by high ulceration, amputation, and foot-related mortality rates. Current guidelines on foot care in diabetes should recognize advanced CKD and ESRD/dialysis as a separate risk factor for foot disease to alert professionals and highlight the opportunity for prevention. Recent studies have demonstrated improved foot outcomes when chiropody programs are instituted within dialysis units.
Literatur
1.
Zurück zum Zitat Singh B, Armstrong DG, Lipsky BA: Preventing foot ulcers in persons with diabetes. JAMA 2005, 293:217–222.CrossRefPubMed Singh B, Armstrong DG, Lipsky BA: Preventing foot ulcers in persons with diabetes. JAMA 2005, 293:217–222.CrossRefPubMed
2.
Zurück zum Zitat Ramsey SD, Newton K, Blough D, et al.: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382–387.CrossRefPubMed Ramsey SD, Newton K, Blough D, et al.: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382–387.CrossRefPubMed
3.
Zurück zum Zitat Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al.: The global burden of diabetic foot disease. Lancet 2005, 366:1719–1724.CrossRefPubMed Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al.: The global burden of diabetic foot disease. Lancet 2005, 366:1719–1724.CrossRefPubMed
4.
Zurück zum Zitat Tennvall GR, Apelqvist J, Eneroth M: Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000, 18:225–238.CrossRefPubMed Tennvall GR, Apelqvist J, Eneroth M: Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000, 18:225–238.CrossRefPubMed
5.
Zurück zum Zitat Prompers L, Huijberts M, Schaper N, et al.: Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia 2008, 51:1826–1834.CrossRefPubMed Prompers L, Huijberts M, Schaper N, et al.: Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia 2008, 51:1826–1834.CrossRefPubMed
6.
Zurück zum Zitat Boddana P, Caskey F, Casula A, et al.: UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons. Nephron Clin Pract 2009, 111:269–276.CrossRef Boddana P, Caskey F, Casula A, et al.: UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons. Nephron Clin Pract 2009, 111:269–276.CrossRef
7.
Zurück zum Zitat U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2008. U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
8.
Zurück zum Zitat Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 1999, 56:1524–1533.CrossRefPubMed Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 1999, 56:1524–1533.CrossRefPubMed
9.
Zurück zum Zitat • Ndip A, Lavery LA, Lafontaine J, et al.: High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care 2010, 33:878–880. This is a large study on diabetic foot disease in dialysis patients involving a representative (ethnically) transatlantic cohort of patients. It demonstrated that the risk for diabetic foot disease in dialysis patients is consistently high across all ethnic groups.CrossRefPubMed • Ndip A, Lavery LA, Lafontaine J, et al.: High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care 2010, 33:878–880. This is a large study on diabetic foot disease in dialysis patients involving a representative (ethnically) transatlantic cohort of patients. It demonstrated that the risk for diabetic foot disease in dialysis patients is consistently high across all ethnic groups.CrossRefPubMed
10.
Zurück zum Zitat •• Margolis DJ, Hofstad O, Feldman HI: Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008, 31:1331–1336. This is a relatively large community-based study demonstrating that there is a progressive rise in the risk of foot diseases with worsening renal impairment, independent of peripheral arterial disease.CrossRefPubMed •• Margolis DJ, Hofstad O, Feldman HI: Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008, 31:1331–1336. This is a relatively large community-based study demonstrating that there is a progressive rise in the risk of foot diseases with worsening renal impairment, independent of peripheral arterial disease.CrossRefPubMed
11.
Zurück zum Zitat Wolf G, Müller N, Busch M, et al.: Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant 2009, 24:1896–1901.CrossRefPubMed Wolf G, Müller N, Busch M, et al.: Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant 2009, 24:1896–1901.CrossRefPubMed
12.
Zurück zum Zitat •• Game FL, Chipchase SY, Hubbard R, et al.: Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 2006, 21:3207–3210. This paper showed that the commencement of dialysis treatment in people with diabetes was associated with a sharp rise in the cumulative incidence of foot ulceration and amputation.CrossRefPubMed •• Game FL, Chipchase SY, Hubbard R, et al.: Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 2006, 21:3207–3210. This paper showed that the commencement of dialysis treatment in people with diabetes was associated with a sharp rise in the cumulative incidence of foot ulceration and amputation.CrossRefPubMed
13.
Zurück zum Zitat Reiber GE, Vileikyte L, Boyko EJ, et al.: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157–162.CrossRefPubMed Reiber GE, Vileikyte L, Boyko EJ, et al.: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157–162.CrossRefPubMed
14.
Zurück zum Zitat Fernando DJS, Hutchison A, Veves A, et al.: Risk Factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991, 8:223–225.CrossRefPubMed Fernando DJS, Hutchison A, Veves A, et al.: Risk Factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991, 8:223–225.CrossRefPubMed
15.
Zurück zum Zitat Raskin NH: Neurological aspects of renal failure. In Neurology and General Medicine, edn 2. Edited by Aminoff MJ. New York: Churchill Livingstone; 1995:303–319. Raskin NH: Neurological aspects of renal failure. In Neurology and General Medicine, edn 2. Edited by Aminoff MJ. New York: Churchill Livingstone; 1995:303–319.
16.
Zurück zum Zitat Krishnan AV, Kiernan MC: Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 2007, 35:273–290.CrossRefPubMed Krishnan AV, Kiernan MC: Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 2007, 35:273–290.CrossRefPubMed
17.
Zurück zum Zitat Dyck PJ, Johnson WJ, Lambert EH, et al.: Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971, 46:400–431.PubMed Dyck PJ, Johnson WJ, Lambert EH, et al.: Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971, 46:400–431.PubMed
18.
Zurück zum Zitat Yosipovitch G, Yarnitsky D, Mermelstein V, et al.: Paradoxical heat sensation in uremic polyneuropathy. Muscle Nerve 1995, 18:768–771.CrossRefPubMed Yosipovitch G, Yarnitsky D, Mermelstein V, et al.: Paradoxical heat sensation in uremic polyneuropathy. Muscle Nerve 1995, 18:768–771.CrossRefPubMed
19.
Zurück zum Zitat D’Amour ML, Dufresne LR, Morin C, et al.: Sensory nerve conduction in chronic uremic patients during the first six months of hemodialysis. Can J Neurol Sci 1984, 11:269–271.PubMed D’Amour ML, Dufresne LR, Morin C, et al.: Sensory nerve conduction in chronic uremic patients during the first six months of hemodialysis. Can J Neurol Sci 1984, 11:269–271.PubMed
20.
Zurück zum Zitat Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, et al.: Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 2000, 248:21–26.CrossRefPubMed Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, et al.: Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 2000, 248:21–26.CrossRefPubMed
21.
Zurück zum Zitat Ogura T, Makinodan A, Kubo T, et al.: Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad Med J 2001, 77:451–454.CrossRefPubMed Ogura T, Makinodan A, Kubo T, et al.: Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad Med J 2001, 77:451–454.CrossRefPubMed
22.
Zurück zum Zitat Wattanakit K, Folsom AR, Selvin E, et al.: Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007, 18:629–636.CrossRefPubMed Wattanakit K, Folsom AR, Selvin E, et al.: Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007, 18:629–636.CrossRefPubMed
23.
Zurück zum Zitat O’Hare AM, Vittinghoff E, Hsia J, et al.: Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the heart and estrogen/progestin replacement study (HERS). J Am Soc Nephrol 2004, 15:1046–1051.CrossRefPubMed O’Hare AM, Vittinghoff E, Hsia J, et al.: Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the heart and estrogen/progestin replacement study (HERS). J Am Soc Nephrol 2004, 15:1046–1051.CrossRefPubMed
24.
Zurück zum Zitat Rajagopalan S, Dellegrottaglie S, Furniss AL, et al.: Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006, 114:1914–1922.CrossRefPubMed Rajagopalan S, Dellegrottaglie S, Furniss AL, et al.: Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006, 114:1914–1922.CrossRefPubMed
25.
Zurück zum Zitat Liu JH, Lin HH, Yang YF, et al.: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int 2009, 29:64–71.PubMed Liu JH, Lin HH, Yang YF, et al.: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int 2009, 29:64–71.PubMed
26.
Zurück zum Zitat Guerrero A, Montes R, Muñoz-Terol J, et al.: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006, 21:3525–3531.CrossRefPubMed Guerrero A, Montes R, Muñoz-Terol J, et al.: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006, 21:3525–3531.CrossRefPubMed
27.
Zurück zum Zitat Leskinen Y, Salenius JP, Lehtimäki T, et al.: The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002, 40:472–479.CrossRefPubMed Leskinen Y, Salenius JP, Lehtimäki T, et al.: The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002, 40:472–479.CrossRefPubMed
28.
Zurück zum Zitat Ix JH, Criqui MH: Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. Adv Chronic Kidney Dis 2008, 15:378–383.CrossRefPubMed Ix JH, Criqui MH: Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. Adv Chronic Kidney Dis 2008, 15:378–383.CrossRefPubMed
29.
Zurück zum Zitat Young MJ, Adams JE, Anderson GF, et al.: Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993, 36:615–621.CrossRefPubMed Young MJ, Adams JE, Anderson GF, et al.: Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993, 36:615–621.CrossRefPubMed
30.
31.
Zurück zum Zitat Ndip A, Jude EB: Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds 2009, 8:82–94.CrossRefPubMed Ndip A, Jude EB: Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds 2009, 8:82–94.CrossRefPubMed
32.
Zurück zum Zitat Aboyans V, Ho E, Denenberg JO, et al.: The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and non-diabetic subjects. J Vasc Surg 2008, 48:1197–1203.CrossRefPubMed Aboyans V, Ho E, Denenberg JO, et al.: The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and non-diabetic subjects. J Vasc Surg 2008, 48:1197–1203.CrossRefPubMed
33.
Zurück zum Zitat O’Hare AM, Hsu CY, Bacchetti P, et al.: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002, 13:497–503.PubMed O’Hare AM, Hsu CY, Bacchetti P, et al.: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002, 13:497–503.PubMed
34.
Zurück zum Zitat Cheung AK, Sarnak MJ, Yan G, et al.: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000, 58:353–362.CrossRefPubMed Cheung AK, Sarnak MJ, Yan G, et al.: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000, 58:353–362.CrossRefPubMed
35.
Zurück zum Zitat Hinchliffe RJ, Kirk B, Bhattacharjee D, et al.: The effect of haemodialysis on transcutaneous oxygen tension in patients with diabetes-a pilot study. Nephrol Dial Transplant 2006, 21:1981–1983.CrossRefPubMed Hinchliffe RJ, Kirk B, Bhattacharjee D, et al.: The effect of haemodialysis on transcutaneous oxygen tension in patients with diabetes-a pilot study. Nephrol Dial Transplant 2006, 21:1981–1983.CrossRefPubMed
36.
Zurück zum Zitat Beckert S, Sundermann K, Wolf S, et al.: Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus. Diabet Med 2009, 26:89–92.CrossRefPubMed Beckert S, Sundermann K, Wolf S, et al.: Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus. Diabet Med 2009, 26:89–92.CrossRefPubMed
37.
Zurück zum Zitat Kato S, Chmielewski M, Honda H, et al.: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008, 3:1526–1533.CrossRefPubMed Kato S, Chmielewski M, Honda H, et al.: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008, 3:1526–1533.CrossRefPubMed
38.
Zurück zum Zitat Ando M, Shibuya A, Yasuda M, et al.: Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005, 2:2497–2503.CrossRef Ando M, Shibuya A, Yasuda M, et al.: Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005, 2:2497–2503.CrossRef
39.
Zurück zum Zitat Anding K, Gross P, Rost JM, et al.: The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003, 18:2067–2073.CrossRefPubMed Anding K, Gross P, Rost JM, et al.: The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003, 18:2067–2073.CrossRefPubMed
40.
Zurück zum Zitat Opatrny K Jr: Clinical importance of biocompatibility and its effect on haemodialysis treatment. Nephrol Dial Transplant 2003, 18:S41–S44.CrossRef Opatrny K Jr: Clinical importance of biocompatibility and its effect on haemodialysis treatment. Nephrol Dial Transplant 2003, 18:S41–S44.CrossRef
41.
Zurück zum Zitat Stenvinkel P, Ketteler M, Johnson RJ, et al.: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 2005, 67:1216–1233.CrossRefPubMed Stenvinkel P, Ketteler M, Johnson RJ, et al.: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 2005, 67:1216–1233.CrossRefPubMed
42.
Zurück zum Zitat Pliakogiannis T, Bailey S, Cherukuri S, et al.: Vascular complications of the lower extremities in diabetic patients on peritoneal dialysis. Clin Nephrol 2008, 69:361–367.PubMed Pliakogiannis T, Bailey S, Cherukuri S, et al.: Vascular complications of the lower extremities in diabetic patients on peritoneal dialysis. Clin Nephrol 2008, 69:361–367.PubMed
43.
Zurück zum Zitat Locking-Cusolito H, Harwood L, Wilson B, et al.: Prevalence of risk factors predisposing to foot problems in patients on hemodialysis. Nephrol Nurs J 2005, 32:373–384.PubMed Locking-Cusolito H, Harwood L, Wilson B, et al.: Prevalence of risk factors predisposing to foot problems in patients on hemodialysis. Nephrol Nurs J 2005, 32:373–384.PubMed
44.
Zurück zum Zitat Thangarajah H, Yao D, Chang EI, et al.: The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 2009, 106:13505–13510.CrossRefPubMed Thangarajah H, Yao D, Chang EI, et al.: The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 2009, 106:13505–13510.CrossRefPubMed
45.
Zurück zum Zitat Lincoln NB, Radford KA, Game FL, et al.: Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008, 51:1954–1961.CrossRefPubMed Lincoln NB, Radford KA, Game FL, et al.: Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008, 51:1954–1961.CrossRefPubMed
46.
Zurück zum Zitat Richbourg MJ: Preventing amputations in patients with end stage renal disease: whatever happened to foot care? ANNA J 1998, 25:13–20.PubMed Richbourg MJ: Preventing amputations in patients with end stage renal disease: whatever happened to foot care? ANNA J 1998, 25:13–20.PubMed
47.
Zurück zum Zitat Lawrence A: Foot care education in renal patients with diabetes. EDTNA ERCA J 2004, 30:153–156.PubMed Lawrence A: Foot care education in renal patients with diabetes. EDTNA ERCA J 2004, 30:153–156.PubMed
48.
Zurück zum Zitat Afsar B, Akman B: Depression and non-adherence are closely related in dialysis patients. Kidney Int 2009, 76:679; author reply 679–680.CrossRefPubMed Afsar B, Akman B: Depression and non-adherence are closely related in dialysis patients. Kidney Int 2009, 76:679; author reply 679–680.CrossRefPubMed
49.
Zurück zum Zitat Hedayati SS, Minhajuddin AT, Toto RD, et al.: Prevalence of major depressive episode in CKD. Am J Kidney Dis 2009, 54:424–432.CrossRefPubMed Hedayati SS, Minhajuddin AT, Toto RD, et al.: Prevalence of major depressive episode in CKD. Am J Kidney Dis 2009, 54:424–432.CrossRefPubMed
50.
Zurück zum Zitat Young BA, Von Korff M, Heckbert SR, et al.: Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010, 32:119–124.CrossRefPubMed Young BA, Von Korff M, Heckbert SR, et al.: Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010, 32:119–124.CrossRefPubMed
51.
Zurück zum Zitat Griffiths GD, Wieman TJ: The influence of renal function on diabetic foot ulceration. Arch Surg 1990, 125:1567–1569.PubMed Griffiths GD, Wieman TJ: The influence of renal function on diabetic foot ulceration. Arch Surg 1990, 125:1567–1569.PubMed
52.
Zurück zum Zitat Guerrero-Romeo F, Rodriguez-Moran M: Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J Diabetes Complications 1998, 12:193–196.CrossRef Guerrero-Romeo F, Rodriguez-Moran M: Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J Diabetes Complications 1998, 12:193–196.CrossRef
53.
Zurück zum Zitat Hill MN, Feldman HI, Hilton SC, et al.: Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study. ANNA J 1996, 23:381–388.PubMed Hill MN, Feldman HI, Hilton SC, et al.: Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study. ANNA J 1996, 23:381–388.PubMed
54.
Zurück zum Zitat McGrath NM, Curran BA: Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population. Diabetes Care 2000, 23:432–433.CrossRefPubMed McGrath NM, Curran BA: Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population. Diabetes Care 2000, 23:432–433.CrossRefPubMed
55.
Zurück zum Zitat Morbach S, Quante C, Ochs HR, et al.: Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. Diabetes Care 2001, 24:1689–1690.CrossRefPubMed Morbach S, Quante C, Ochs HR, et al.: Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. Diabetes Care 2001, 24:1689–1690.CrossRefPubMed
56.
Zurück zum Zitat Ndip A, Rutter MK, Vileikyte L, et al.: Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 2010, doi:10.2337/dc10-0255. Ndip A, Rutter MK, Vileikyte L, et al.: Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 2010, doi:10.​2337/​dc10-0255.
57.
Zurück zum Zitat Speckman RA, Frankenfield DL, Roman SH, et al.: Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care 2004, 27: 2198–2203.CrossRefPubMed Speckman RA, Frankenfield DL, Roman SH, et al.: Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care 2004, 27: 2198–2203.CrossRefPubMed
58.
Zurück zum Zitat O’Hare AM, Feinglass J, Reiber GE, et al.: Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency. J Am Soc Nephrol 2004, 15:427–434.CrossRefPubMed O’Hare AM, Feinglass J, Reiber GE, et al.: Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency. J Am Soc Nephrol 2004, 15:427–434.CrossRefPubMed
59.
Zurück zum Zitat • Lavery LA, Hunt NA, Lafontaine J, et al.: Diabetic foot prevention: a neglected opportunity in high risk patients. Diabetes Care 2010 Apr 27 [Epub ahead of print]. This paper demonstrated that foot care prevention services are not being offered to dialysis patients despite these individuals being at very high risk for developing diabetic foot complications. • Lavery LA, Hunt NA, Lafontaine J, et al.: Diabetic foot prevention: a neglected opportunity in high risk patients. Diabetes Care 2010 Apr 27 [Epub ahead of print]. This paper demonstrated that foot care prevention services are not being offered to dialysis patients despite these individuals being at very high risk for developing diabetic foot complications.
60.
Zurück zum Zitat Gandhi GY, Roger VL, Bailey KR, et al.: Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survival. Mayo Clin Proc 2006, 81:1034–1040.CrossRefPubMed Gandhi GY, Roger VL, Bailey KR, et al.: Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survival. Mayo Clin Proc 2006, 81:1034–1040.CrossRefPubMed
61.
Zurück zum Zitat Gunarathne A, Patel JV, Potluri R, et al.: Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract 2008, 62:197–201.PubMed Gunarathne A, Patel JV, Potluri R, et al.: Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract 2008, 62:197–201.PubMed
62.
Zurück zum Zitat Hambleton IR, Jonnalagadda R, Davis CR, et al.: All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care 2009, 32:306–307.CrossRefPubMed Hambleton IR, Jonnalagadda R, Davis CR, et al.: All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care 2009, 32:306–307.CrossRefPubMed
63.
Zurück zum Zitat Lipscombe J, Jassal SV, Bailey S, et al.: Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003, 23:255–259.PubMed Lipscombe J, Jassal SV, Bailey S, et al.: Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003, 23:255–259.PubMed
64.
Zurück zum Zitat Neil JA, Knuckey CJ, Tanenberg RJ: Prevention of foot ulcers in patients with diabetes and end stage renal disease. Nephrol Nurs J 2003, 30:39–43.PubMed Neil JA, Knuckey CJ, Tanenberg RJ: Prevention of foot ulcers in patients with diabetes and end stage renal disease. Nephrol Nurs J 2003, 30:39–43.PubMed
65.
Zurück zum Zitat Foster AV, Snowden S, Grenfell A, et al.: Reduction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic. Diabet Med 1995, 12:632–635.CrossRefPubMed Foster AV, Snowden S, Grenfell A, et al.: Reduction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic. Diabet Med 1995, 12:632–635.CrossRefPubMed
66.
Zurück zum Zitat Rith-Najarian S, Branchaud C, Beaulieu O, et al.: Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract 1998, 47:127–132.PubMed Rith-Najarian S, Branchaud C, Beaulieu O, et al.: Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract 1998, 47:127–132.PubMed
67.
Zurück zum Zitat Lavery LA, Wunderlich RP, Tredwell JL: Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005, 70:31–37.CrossRefPubMed Lavery LA, Wunderlich RP, Tredwell JL: Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005, 70:31–37.CrossRefPubMed
68.
Zurück zum Zitat Uccioli L, Faglia E, Monticone G, et al.: Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995, 18:1376–1378.CrossRefPubMed Uccioli L, Faglia E, Monticone G, et al.: Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995, 18:1376–1378.CrossRefPubMed
69.
Zurück zum Zitat Plank J, Haas W, Rakovac I, et al.: Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care 2003, 26:1691–1695.CrossRefPubMed Plank J, Haas W, Rakovac I, et al.: Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care 2003, 26:1691–1695.CrossRefPubMed
Metadaten
Titel
Diabetic Foot Disease in People with Advanced Nephropathy and Those on Renal Dialysis
verfasst von
Agbor Ndip
Lawrence A. Lavery
Andrew J. M. Boulton
Publikationsdatum
01.08.2010
Verlag
Current Science Inc.
Erschienen in
Current Diabetes Reports / Ausgabe 4/2010
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-010-0128-0

Weitere Artikel der Ausgabe 4/2010

Current Diabetes Reports 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.